发明名称 |
Sustained release preparation of pro-insulin C-peptide |
摘要 |
The present invention provides a pharmaceutical composition for the sustained release of C-peptide. The composition is in the form of a gel containing C-peptide. The gel formation is achieved by the adjustment of pH of the composition and/or by addition of divalent metal ions. The composition does not include any other gel-forming agents. Methods for producing the composition, medical uses of the composition and products containing two or more gel compositions as a combined preparation are also encompassed. |
申请公布号 |
US8927489(B2) |
申请公布日期 |
2015.01.06 |
申请号 |
US200611916116 |
申请日期 |
2006.06.02 |
申请人 |
Cebix Incorporated |
发明人 |
Wahren John;Carlsson Anders |
分类号 |
A61K38/28;A61K38/00;A61K38/16;A61K38/10;A61K38/08;A61K38/06;A61K38/04;A61K9/00;A61K47/02 |
主分类号 |
A61K38/28 |
代理机构 |
Morrison & Foerster LLP |
代理人 |
Morrison & Foerster LLP |
主权项 |
1. A pharmaceutical composition for the sustained release of C-peptide said composition being in the form of a gel comprising colloidal C-peptide,
wherein said C-peptide is full length as disclosed in SEQ. ID. Nos. 1-24, or a fragment of each one thereof comprising residues 15-31 when at least 31 residues are present, or as disclosed in SEQ. ID. Nos. 25-31, wherein gel formation is induced by the adjustment of pH of said composition and/or by addition of divalent metal ions, and wherein said composition does not include any gel-forming agents, other than metal ions, if present. |
地址 |
San Diego CA US |